Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-19T19:28:09.738Z Has data issue: false hasContentIssue false

Chapter 13 - Management of Cerebral Venous Thrombosis in the Neurocritical Care Unit

Published online by Cambridge University Press:  24 July 2019

By
Xiaomeng Xu ,
Xiaoying Yao  and
Magdy Selim
Edited by
Michel T. Torbey
Michel T. Torbey
Affiliation:
Ohio State University
Get access

Summary

Cerebral venous thrombosis (CVT) refers to clot formation within the dural venous sinuses or the cerebral venous drainage system. The most commonly affected sinuses are the superior sagittal sinus, transverse sinuses, straight sinus, cortical veins, internal jagular veins, and deep veins.

Type
Chapter
Information
Neurocritical Care , pp. 146 - 153
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Coutinho, JM, Zuurbier, SM, Aramideh, M, Stam, J (2012). The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke 43(12): 3375–3377.CrossRefGoogle ScholarPubMed
Devasagayam, S, Wyatt, B, Leyden, J, Kleinig, T (2016). Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke 47(9): 2180–2182.CrossRefGoogle ScholarPubMed
Silvis, SM, de Sousa, DA, Ferro, JM, Coutinho, JM (2017). Cerebral venous thrombosis. Nat Rev Neurol 13(9): 555–565.CrossRefGoogle ScholarPubMed
Ferro, JM, Canhao, P, Bousser, MG, et al. (2005). Cerebral vein and dural sinus thrombosis in elderly patients. Stroke 36(9): 1927–1932.CrossRefGoogle ScholarPubMed
Ferro, JM, Canhao, P (2014). Cerebral venous sinus thrombosis: update on diagnosis and management. Curr Cardiol Rep 16(9): 523.CrossRefGoogle ScholarPubMed
Kovacs, MJ (2011). Letter by Kovacs regarding article, “Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association”. Stroke 42(7): e408.Google Scholar
Aguiar de Sousa, D, Canhao, P, Crassard, I, et al. (2017). Safety of pregnancy after cerebral venous thrombosis: results of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis)-2 PREGNANCY Study. Stroke 48(11): 3130–3133.Google Scholar
Saposnik, G, Barinagarrementeria, F, Brown, RD Jr., et al. (2011). Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(4): 1158–1192.CrossRefGoogle ScholarPubMed
Long, B, Koyfman, A, Runyon, MS (2017). Cerebral venous thrombosis: a challenging neurologic diagnosis. Emerg Med Clin North Am 35(4): 869–878.Google Scholar
Ferro, JM, Canhao, P, Stam, J, et al. (2004). Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35(3): 664–670.CrossRefGoogle Scholar
Ferro, JM, Bacelar-Nicolau, H, Rodrigues, T, et al. (2009). Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis 28(1): 39–44.CrossRefGoogle ScholarPubMed
Koopman, K, Uyttenboogaart, M, Vroomen, PC, et al. (2009). Development and validation of a predictive outcome score of cerebral venous thrombosis. J Neurol Sci 276(1–2): 66–68.CrossRefGoogle ScholarPubMed
Einhaupl, KM, Villringer, A, Meister, W, et al. (1991). Heparin treatment in sinus venous thrombosis. Lancet 338(8767): 597–600.Google Scholar
de Bruijn, SF, Stam, J (1999). Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30(3): 484–488.Google Scholar
Stam, J, De Bruijn, SF, DeVeber, G (2002). Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev (4): CD002005.Google Scholar
Misra, UK, Kalita, J, Chandra, S, Kumar, B, Bansal, V (2012). Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial. Eur J Neurol 19(7): 1030–1036.CrossRefGoogle ScholarPubMed
Coutinho, JM, Ferro, JM, Zuurbier, SM, et al. (2013). Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial. Int J Stroke 8(2): 135–140.CrossRefGoogle ScholarPubMed
Siddiqui, FM, Dandapat, S, Banerjee, C, et al. (2015). Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases. Stroke 46(5): 1263–1268.Google Scholar
Ameri, A, Bousser, MG (1992). Cerebral venous thrombosis. Neurol Clin 10(1): 87–111.CrossRefGoogle ScholarPubMed
Ferro, JM, Canhao, P, Stam, J, et al. (2009). Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke 40(9): 3133–3138.Google Scholar
Biousse, V, Ameri, A, Bousser, MG (1999). Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 53(7): 1537–1542.Google Scholar
Hanley, DF, Feldman, E, Borel, CO, Rosenbaum, AE, Goldberg, AL (1988). Treatment of sagittal sinus thrombosis associated with cerebral hemorrhage and intracranial hypertension. Stroke 19(7): 903–909.Google Scholar
Vahedi, K, Hofmeijer, J, Juettler, E, et al. (2007). Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6(3): 215–222.Google Scholar
Canhao, P, Cortesao, A, Cabral, M, et al. (2008). Are steroids useful to treat cerebral venous thrombosis? Stroke 39(1): 105–110.Google Scholar
Masuhr, F, Busch, M, Amberger, N, et al. (2006). Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol 13(8): 852–856.Google Scholar
Sha, DJ, Qian, J, Gu, SS, et al. (2018). Cerebral venous sinus thrombosis complicated by seizures: a retrospective analysis of 69 cases. J Thromb Thrombolysis 45(1): 186–191.CrossRefGoogle ScholarPubMed
Warkentin, TE, Greinacher, A (2004). Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl): 311S-337S.Google Scholar
Warkentin, TE, Greinacher, A (2016). Management of heparin-induced thrombocytopenia. Curr Opin Hematol 23(5): 462–470.Google Scholar
Linkins, LA, Dans, AL, Moores, LK, et al. (2012). Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl): e495S-e530S.Google Scholar
Geisbusch, C, Richter, D, Herweh, C, Ringleb, PA, Nagel, S (2014). Novel factor Xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients. Stroke 45(8): 2469–2471.Google Scholar
Mendonca, MD, Barbosa, R, Cruz-e-Silva, V, Calado, S, Viana-Baptista, M (2015). Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients. Int J Stroke 10(7): 1115–1118.Google Scholar
Ferro, JM, Bousser, MG, Canhao, P, et al. (2017). European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol 24(10): 1203–1213.Google Scholar
Bain, E, Wilson, A, Tooher, R, et al. (2014). Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev (2): CD001689.Google Scholar
Aguiar de Sousa, D, Canhao, P, Ferro, JM (2016). Safety of pregnancy after cerebral venous thrombosis: a systematic review. Stroke 47(3): 713–718.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×